Cannabinoid receptor 2 counteracts interleukin‐17‐induced immune and fibrogenic responses in mouse liver

Cannabinoid receptor 2 counteracts interleukin‐17‐induced immune and fibrogenic responses in... Interleukin (IL)‐17 is a proinflammatory and fibrogenic cytokine mainly produced by T‐helper (Th)17 lymphocytes, together with the hepatoprotective and antifibrogenic cytokine, IL‐22. Cannabinoid receptor 2 (CB2) is predominantly expressed in immune cells and displays anti‐inflammatory and antifibrogenic effects. In the present study, we further investigated the mechanism underlying antifibrogenic properties of CB2 receptor and explored its effect on the profibrogenic properties of IL‐17. After bile duct ligation (BDL), the hepatic expression of Th17 markers and IL‐17 production were enhanced in CB2−/− mice, as compared to wild‐type (WT) counterparts, and correlated with increased fibrosis in these animals. In contrast, IL‐22‐induced expression was similar in both animal groups. Inhibition of Th17 differentiation by digoxin lowered Th17 marker gene expression and IL‐17 production and strongly reduced liver fibrosis in CB2−/− BDL mice. In vitro, differentiation of CD4+ naïve T cells into Th17 lymphocytes was decreased by the CB2 agonist, JWH‐133, and was associated with reduced Th17 marker messenger RNA expression and IL‐17 production, without modification of IL‐22 release. The inhibitory effect of JWH‐133 on IL‐17 production relied on signal transducer and activator of transcription (STAT)5 phosphorylation. Indeed, STAT5 phosphorylation and translocation into the nucleus was enhanced in JWH133‐treated Th17 lymphocytes, and the addition of a STAT5 inhibitor reversed the inhibitory effect of the CB2 agonist on IL‐17 production, without affecting IL‐22 levels. Finally, in vitro studies also demonstrated that CB2 receptor activation in macrophages and hepatic myofibroblasts blunts IL‐17‐induced proinflammatory gene expression. Conclusion: These data demonstrate that CB2 receptor activation decreases liver fibrosis by selectively reducing IL‐17 production by Th17 lymphocytes via a STAT5‐dependent pathway, and by blunting the proinflammatory effects of IL‐17 on its target cells, while preserving IL‐22 production. (Hepatology 2014;58:296–306) http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Hepatology Wiley

Cannabinoid receptor 2 counteracts interleukin‐17‐induced immune and fibrogenic responses in mouse liver

Loading next page...
 
/lp/wiley/cannabinoid-receptor-2-counteracts-interleukin-17-induced-immune-and-gcC9fc0wNc
Publisher
Wiley
Copyright
© 2013 by the American Association for the Study of Liver Diseases
ISSN
0270-9139
eISSN
1527-3350
DOI
10.1002/hep.26598
Publisher site
See Article on Publisher Site

Abstract

Interleukin (IL)‐17 is a proinflammatory and fibrogenic cytokine mainly produced by T‐helper (Th)17 lymphocytes, together with the hepatoprotective and antifibrogenic cytokine, IL‐22. Cannabinoid receptor 2 (CB2) is predominantly expressed in immune cells and displays anti‐inflammatory and antifibrogenic effects. In the present study, we further investigated the mechanism underlying antifibrogenic properties of CB2 receptor and explored its effect on the profibrogenic properties of IL‐17. After bile duct ligation (BDL), the hepatic expression of Th17 markers and IL‐17 production were enhanced in CB2−/− mice, as compared to wild‐type (WT) counterparts, and correlated with increased fibrosis in these animals. In contrast, IL‐22‐induced expression was similar in both animal groups. Inhibition of Th17 differentiation by digoxin lowered Th17 marker gene expression and IL‐17 production and strongly reduced liver fibrosis in CB2−/− BDL mice. In vitro, differentiation of CD4+ naïve T cells into Th17 lymphocytes was decreased by the CB2 agonist, JWH‐133, and was associated with reduced Th17 marker messenger RNA expression and IL‐17 production, without modification of IL‐22 release. The inhibitory effect of JWH‐133 on IL‐17 production relied on signal transducer and activator of transcription (STAT)5 phosphorylation. Indeed, STAT5 phosphorylation and translocation into the nucleus was enhanced in JWH133‐treated Th17 lymphocytes, and the addition of a STAT5 inhibitor reversed the inhibitory effect of the CB2 agonist on IL‐17 production, without affecting IL‐22 levels. Finally, in vitro studies also demonstrated that CB2 receptor activation in macrophages and hepatic myofibroblasts blunts IL‐17‐induced proinflammatory gene expression. Conclusion: These data demonstrate that CB2 receptor activation decreases liver fibrosis by selectively reducing IL‐17 production by Th17 lymphocytes via a STAT5‐dependent pathway, and by blunting the proinflammatory effects of IL‐17 on its target cells, while preserving IL‐22 production. (Hepatology 2014;58:296–306)

Journal

HepatologyWiley

Published: Jan 1, 2014

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off